4//SEC Filing
Odegard Valerie 4
Accession 0001209191-22-006434
CIK 0001671858other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:16 PM ET
Size
9.6 KB
Accession
0001209191-22-006434
Insider Transaction Report
Form 4
Odegard Valerie
President and CSO
Transactions
- Award
Stock Option (right to buy)
2022-02-01+98,438→ 98,438 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (98,438 underlying) - Award
Common Stock
2022-02-01+16,406→ 16,406 total - Award
Stock Option (right to buy)
2022-02-01+49,875→ 49,875 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (49,875 underlying)
Footnotes (3)
- [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The shares subject to the option vest in equal monthly installments over the 48 months following February 1, 2022.
- [F3]25% of the shares subject to the option vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years.
Documents
Issuer
Silverback Therapeutics, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001832432
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:16 PM ET
- Size
- 9.6 KB